Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinoma, Transitional Cell
×
tremelimumab
×
Clear all
Filters
3
NCT03871036
2025-03-06
ICRA
The Netherlands Cancer Institute
Phase 1/2
Completed
53 enrolled
NCT03317158
2025-01-30
ADAPT-BLADDER
Hoosier Cancer Research Network
Phase 1/2
Recruiting
55 enrolled